• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童横纹肌肉瘤异种移植瘤的生长与特性研究

Growth and characterization of childhood rhabdomyosarcomas as xenografts.

作者信息

Houghton J A, Houghton P J, Webber B L

出版信息

J Natl Cancer Inst. 1982 Mar;68(3):437-43.

PMID:6950170
Abstract

Eleven surgical specimens of childhood rhabdomyosarcoma (RMS), two bone marrow samples, and cells from ascitic fluid from 1 patient were implanted sc into immune-deprived inbred CBA/CaJ mice. From these, seven lines of RMS were obtained as xenografts, each retaining the histologic characteristics of the tumor of origin and human lactate dehydrogenase isozymes; these represented 6 of the 11 surgical specimens, whereas one line originated from the transplanted cells from ascitic fluid. It was concluded that children RMS has a fairly high frequency of heterotransplantability in this system and that such a laboratory model may prove useful in the development of new therapeutic regimens in this disease.

摘要

将11例儿童横纹肌肉瘤(RMS)手术标本、2份骨髓样本以及1例患者腹水细胞皮下植入免疫缺陷的近交系CBA/CaJ小鼠体内。从中获得了7株RMS异种移植瘤系,每株均保留了原发肿瘤的组织学特征及人乳酸脱氢酶同工酶;这些代表了11例手术标本中的6例,而1株来源于腹水移植细胞。得出的结论是,儿童RMS在该系统中具有相当高的异种移植成功率,并且这样的实验室模型可能在该疾病新治疗方案的开发中证明是有用的。

相似文献

1
Growth and characterization of childhood rhabdomyosarcomas as xenografts.儿童横纹肌肉瘤异种移植瘤的生长与特性研究
J Natl Cancer Inst. 1982 Mar;68(3):437-43.
2
Development and characterization of pediatric osteosarcoma xenografts.
Cancer Res. 1990 May 1;50(9):2781-5.
3
Melphalan: a potential new agent in the treatment of childhood rhabdomyosarcoma.
Cancer Treat Rep. 1985 Jan;69(1):91-6.
4
Chemotherapy of childhood rhabdomyosarcomas growing as xenografts in immune-deprived mice.在免疫缺陷小鼠体内异种移植生长的儿童横纹肌肉瘤的化疗
Cancer Res. 1982 Feb;42(2):535-9.
5
Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma.源自儿童横纹肌肉瘤异种移植瘤的细胞系的特征分析
Cancer Res. 1987 Aug 15;47(16):4501-7.
6
Xenografts of human bladder cancer in immune-deprived mice.免疫缺陷小鼠体内的人膀胱癌异种移植
Cancer Res. 1982 Sep;42(9):3696-703.
7
Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.拓扑替康与长春新碱联合治疗小儿实体瘤异种移植瘤的协同作用。
Clin Cancer Res. 1999 Nov;5(11):3617-31.
8
[Rhabdomyosarcoma lysis by T cells expressing a human autoantibody based chimeric receptor targeting the fetal acetylcholine receptors].[通过表达靶向胎儿乙酰胆碱受体的基于人自身抗体的嵌合受体的T细胞溶解横纹肌肉瘤]
Verh Dtsch Ges Pathol. 2006;90:264-76.
9
Characterization of human ovarian carcinomas in a SCID mouse model.人卵巢癌在SCID小鼠模型中的特征描述。
Gynecol Oncol. 1999 Feb;72(2):161-70. doi: 10.1006/gyno.1998.5238.
10
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.甲硝唑增强卡莫司汀和美法仑对人黑色素瘤异种移植瘤的作用。
Am J Clin Oncol. 1982 Feb;5(1):73-8.

引用本文的文献

1
Comprehensive characterization of patient-derived xenograft models of pediatric leukemia.儿童白血病患者来源异种移植模型的全面表征
iScience. 2023 Oct 10;26(11):108171. doi: 10.1016/j.isci.2023.108171. eCollection 2023 Nov 17.
2
EphA1 receptor tyrosine kinase is localized to the nucleus in rhabdomyosarcoma from multiple species.EphA1 受体酪氨酸激酶在多种物种的横纹肌肉瘤中定位于细胞核。
Biol Open. 2022 Oct 15;11(10). doi: 10.1242/bio.059352. Epub 2022 Oct 10.
3
Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing.
开发治疗儿童癌症的新药物:临床前测试的挑战与机遇
J Clin Med. 2021 Apr 4;10(7):1504. doi: 10.3390/jcm10071504.
4
PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.PCAT:一个整合了儿科癌症患者来源异种移植模型基因组和临床前测试数据的门户。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1321-D1327. doi: 10.1093/nar/gkaa698.
5
Challenges and Opportunities for Childhood Cancer Drug Development.儿童癌症药物研发的挑战与机遇。
Pharmacol Rev. 2019 Oct;71(4):671-697. doi: 10.1124/pr.118.016972.
6
Patient-derived xenograft models in musculoskeletal malignancies.患者来源异种移植模型在肌肉骨骼恶性肿瘤中的应用。
J Transl Med. 2018 Apr 23;16(1):107. doi: 10.1186/s12967-018-1487-6.
7
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis.替代体内药物筛选方法的评估:单只小鼠分析
Cancer Res. 2016 Oct 1;76(19):5798-5809. doi: 10.1158/0008-5472.CAN-16-0122. Epub 2016 Aug 5.
8
FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.FANCD2是一种携带PAX3-FOXO1融合基因的肺泡横纹肌肉瘤的潜在治疗靶点和生物标志物。
Clin Cancer Res. 2014 Jul 15;20(14):3884-95. doi: 10.1158/1078-0432.CCR-13-0556. Epub 2014 Apr 30.
9
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.用于横纹肌肉瘤研究的人横纹肌肉瘤细胞系:效用和陷阱。
Front Oncol. 2013 Jul 17;3:183. doi: 10.3389/fonc.2013.00183. eCollection 2013.
10
Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma.基于细胞的小分子化合物筛选鉴定芬维 A 酯为潜在的转位阳性横纹肌肉瘤治疗药物。
PLoS One. 2013;8(1):e55072. doi: 10.1371/journal.pone.0055072. Epub 2013 Jan 25.